Prostaglandins in human cartilage metabolism

Area of Science:

• Biochemistry
• Cell Biology
• Rheumatology

Background:

• Interleukin 1 (IL1) significantly inhibits glycosaminoglycan (GAG) synthesis in human cartilage, contributing to osteoarthritis (OA) pathogenesis by hindering matrix repair.
• Prostaglandins (PGs) regulate IL1 synthesis; thus, the PG analogue Misoprostol may counteract IL1's inhibitory effects by suppressing positive feedback loops.

Purpose of the Study:

• To investigate the role of IL1 and PGs in cartilage metabolism.
• To evaluate the potential of Misoprostol to enhance GAG synthesis and cartilage repair, particularly in the context of NSAID use.

Main Methods:

• Assessing the sensitivity of human cartilage (both non-arthritic and arthritic) to IL1-induced inhibition of GAG synthesis.
• Examining the effects of Misoprostol on IL1 synthesis and GAG production in cartilage, with and without NSAIDs (Indomethacin, Ibuprofen, Naproxen, Diclofenac).

Main Results:

• Low concentrations of IL1 strongly inhibit GAG synthesis in human cartilage.
• Misoprostol partially reversed the inhibitory effects of certain NSAIDs on GAG synthesis and significantly increased the low GAG synthetic activity in OA cartilages.
• Diclofenac-treated cartilage showed increased GAG synthesis in response to Misoprostol, even without significant chondrocyte metabolism inhibition.

Conclusions:

• Misoprostol demonstrates potential to increase the repair capacity of human OA cartilage.
• Misoprostol may be particularly beneficial for OA cartilage repair during treatment with NSAIDs, by counteracting their inhibitory effects on GAG synthesis.